{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T06:33:09Z","timestamp":1792045989587,"version":"4.4.0"},"reference-count":57,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2004,10,21]],"date-time":"2004-10-21T00:00:00Z","timestamp":1098316800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurogastroenterology Motil"],"published-print":{"date-parts":[[2004,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Neurogenic mechanisms have been implicated in the induction of inflammatory bowel disease (IBD). Vanilloid receptor type 1 (TRPV1) has been visualized on nerve terminals of intrinsic and extrinsic afferent neurones innervating the gastrointestinal tract and local administration of a TRPV1 antagonist, capsazepine, reduces the severity of dextran sulphate sodium (DSS)\u2010induced colitis in rats (<jats:italic>Gut<\/jats:italic> 2003; <jats:bold><jats:italic>52<\/jats:italic><\/jats:bold>: 713\u20139<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"#b1\"><jats:sup>1<\/jats:sup><\/jats:ext-link>). Our aim was to test whether systemically or orally administered TRPV1 antagonists attenuate experimental colitis induced by 5% DSS in Balb\/c mice. Intraperitoneal capsazepine (2.5\u2003mg\u2003kg<jats:sup>\u22121<\/jats:sup>, bid), significantly reduced the overall macroscopic damage severity compared with vehicle\u2010treated animals (80% inhibition, <jats:italic>P<\/jats:italic>\u2003&lt;\u20030.05); however, there was no effect on myeloperoxidase (MPO) levels. An experimental TRPV1 antagonist given orally was tested against DSS\u2010induced colitis, and shown to reverse the macroscopic damage score at doses of 0.5 and 5.0\u2003mg\u2003kg<jats:sup>\u22121<\/jats:sup>. Epithelial damage assessed microscopically was significantly reduced. MPO levels were attenuated by approximately 50%, and diarrhoea scores were reduced by as much as 70%. These results suggest that pharmacological modulation of TRPV1 attenuates indices of experimental colitis in mice, and that development of orally active TRPV1 antagonists might have therapeutic potential for the treatment of IBD.<\/jats:p>","DOI":"10.1111\/j.1365-2982.2004.00549.x","type":"journal-article","created":{"date-parts":[[2004,12,3]],"date-time":"2004-12-03T17:04:03Z","timestamp":1102093443000},"page":"811-818","source":"Crossref","is-referenced-by-count":107,"title":["Vanilloid receptor 1 antagonists attenuate disease severity in dextran sulphate sodium\u2010induced colitis in mice"],"prefix":"10.1111","volume":"16","author":[{"given":"E. S.","family":"Kimball","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. H.","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. R.","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. R.","family":"D'Andrea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. J.","family":"Hornby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2004,10,21]]},"reference":[{"key":"e_1_2_12_2_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.52.5.713"},{"key":"e_1_2_12_3_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.20.100301.064816"},{"key":"e_1_2_12_4_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2002-32233"},{"key":"e_1_2_12_5_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.85.9.3235"},{"key":"e_1_2_12_6_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1026639509036"},{"key":"e_1_2_12_7_2","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.137.4.439"},{"key":"e_1_2_12_8_2","first-page":"G151","article-title":"Integrative immunophysiology in the intestinal mucosa","volume":"267","author":"Perdue MH","year":"1994","journal-title":"Am J Physiol"},{"key":"e_1_2_12_9_2","doi-asserted-by":"publisher","DOI":"10.1080\/003655201750153278"},{"key":"e_1_2_12_10_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00114.2001"},{"key":"e_1_2_12_11_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01538134"},{"key":"e_1_2_12_12_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01534465"},{"key":"e_1_2_12_13_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0705249"},{"key":"e_1_2_12_14_2","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.2002.035147"},{"key":"e_1_2_12_15_2","first-page":"247","article-title":"Nepadutant pharmacokinetics and dose\u2010effect relationships as tachykinin NK2 receptor antagonist are altered by intestinal inflammation in rodent models","volume":"299","author":"Lecci A","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_12_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1827.1994.tb01723.x"},{"key":"e_1_2_12_17_2","doi-asserted-by":"publisher","DOI":"10.1038\/18906"},{"key":"e_1_2_12_18_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.neuro.24.1.487"},{"key":"e_1_2_12_19_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M101607200"},{"key":"e_1_2_12_20_2","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.2002.022848"},{"key":"e_1_2_12_21_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0703050"},{"key":"e_1_2_12_22_2","doi-asserted-by":"publisher","DOI":"10.1038\/22761"},{"key":"e_1_2_12_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3959(00)00366-3"},{"key":"e_1_2_12_24_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2982.2003.00384.x"},{"key":"e_1_2_12_25_2","doi-asserted-by":"publisher","DOI":"10.1309\/7AYY-VVH1-GQT5-J4R2"},{"key":"e_1_2_12_26_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0702810"},{"key":"e_1_2_12_27_2","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.2001.4482"},{"key":"e_1_2_12_28_2","doi-asserted-by":"publisher","DOI":"10.1080\/000163502753509455"},{"key":"e_1_2_12_29_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.2001.00193.x"},{"key":"e_1_2_12_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3940(01)02480-6"},{"key":"e_1_2_12_31_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00441-002-0682-0"},{"key":"e_1_2_12_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)04503-7"},{"key":"e_1_2_12_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0196-9781(01)00463-6"},{"key":"e_1_2_12_34_2","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.102.043893"},{"key":"e_1_2_12_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0952-7915(99)00032-1"},{"key":"e_1_2_12_36_2","first-page":"238","article-title":"Lab Invest. Clinicopathologic study of dextran sulfate sodium experimental murine colitis","volume":"69","author":"Cooper HS","year":"1993","journal-title":"Lab Invest."},{"key":"e_1_2_12_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)65087-0"},{"key":"e_1_2_12_38_2","doi-asserted-by":"publisher","DOI":"10.1159\/000007822"},{"key":"e_1_2_12_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(90)90290-H"},{"key":"e_1_2_12_40_2","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6890-1-3"},{"key":"e_1_2_12_41_2","doi-asserted-by":"publisher","DOI":"10.1002\/1521-4141(200206)32:6<1753::AID-IMMU1753>3.0.CO;2-2"},{"key":"e_1_2_12_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-0115(97)01064-1"},{"key":"e_1_2_12_43_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00488.2002"},{"key":"e_1_2_12_44_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0704220"},{"key":"e_1_2_12_45_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02282350"},{"key":"e_1_2_12_46_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.9.4788"},{"key":"e_1_2_12_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0143-4179(97)90022-6"},{"key":"e_1_2_12_48_2","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.4049\/jimmunol.162.3.1656","article-title":"VCAM\u20101 expression on human dermal microvascular endothelial cells is directly and specifically up\u2010regulated by substance P","volume":"162","author":"Quinlan KL","year":"1999","journal-title":"J Immunol"},{"key":"e_1_2_12_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/0196-9781(95)00037-K"},{"key":"e_1_2_12_50_2","first-page":"433","article-title":"Tumor necrosis factor\u2010alpha, interleukin\u20108 and chemotactic cytokines","volume":"349","author":"Kunkel SL","year":"1990","journal-title":"Prog Clin Biol Res"},{"key":"e_1_2_12_51_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.167.5.2772"},{"key":"e_1_2_12_52_2","doi-asserted-by":"publisher","DOI":"10.1006\/cyto.1996.0195"},{"key":"e_1_2_12_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-8993(02)03972-0"},{"key":"e_1_2_12_54_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00169311"},{"key":"e_1_2_12_55_2","doi-asserted-by":"publisher","DOI":"10.1016\/0143-4179(91)90111-U"},{"key":"e_1_2_12_56_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3940(01)02021-3"},{"key":"e_1_2_12_57_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.2000.279.6.G1298"},{"key":"e_1_2_12_58_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(03)80700-X"}],"container-title":["Neurogastroenterology &amp; Motility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2982.2004.00549.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2982.2004.00549.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T12:40:23Z","timestamp":1697028023000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2982.2004.00549.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,10,21]]},"references-count":57,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2004,12]]}},"alternative-id":["10.1111\/j.1365-2982.2004.00549.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2982.2004.00549.x","archive":["Portico"],"relation":{},"ISSN":["1350-1925","1365-2982"],"issn-type":[{"value":"1350-1925","type":"print"},{"value":"1365-2982","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,10,21]]}}}